TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021.
Read more here.
![[Sayata in PR Newswire] Sayata introduces the ultimate broker/agent insurance distribution engine: RSA 2.0](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
